Amicus Therapeutics (FOLD) Misses Q4 EPS by 6c

Amicus Therapeutics (NASDAQ: FOLD) reported Q4 EPS of ($0.24), $0.06 worse than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Amicus Therapeutics (FOLD) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Carnival shares drop despite earnings beat on weak guidance
• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity